By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DBV Technologies 

29 rue du Faubourg

Saint Jacques  Paris  75014  France
Phone: 33-0-1-55-389270 Fax: 33-0-1-41-312882


Company News
DBV Tech To Present Data At The 2017 AAAAI Meeting Highlighting The Therapeutic Potential Of EPIT 2/13/2017 1:47:15 PM
DBV Tech Announces Completion Of Enrollment Of Phase IIA Study Of Viaskin Milk For The Treatment Of Pediatric Eosinophilic Esophagitis 2/3/2017 11:39:13 AM
DBV Tech Announces Financial Calendar 2017 1/9/2017 9:57:17 AM
DBV Tech, BioNet-Asia And Geneva University Hospitals Complete Dosing In First Cohort Of Phase I Study Of Viaskin Rpt For Booster Vaccination Against Pertussis 11/17/2016 11:39:27 AM
DBV Tech Completes Enrollment Of Phase II Study Of Viaskin Milk For The Treatment Of Milk Allergic Patients 11/8/2016 10:41:42 AM
There's A Patch That Could Fix Your Peanut Allergy Problem, DBV Tech Reveals 11/2/2016 7:06:52 AM
DBV Tech Announces Publication Of Positive Viaskin Peanut Data From NIAID-Sponsored Phase II Academic Study In The Journal Of Allergy And Clinical Immunology 10/27/2016 11:54:23 AM
The First Peanut Allergy Therapy Might Soon Hit The Shelves, DBV Tech Reveals 10/26/2016 6:59:13 AM
DBV Tech Release: Topline Results From Two-Year Follow-Up Study Of Viaskin Peanut Show Long-Lasting And High Levels Of Desensitization To Peanut 10/25/2016 12:17:34 PM
DBV Tech Receives FDA Fast Track Designation For Viaskin Milk For The Treatment Of Cow’s Milk Protein Allergy 9/21/2016 9:12:32 AM